144 related articles for article (PubMed ID: 28257797)
21. Hierarchical and Redundant Roles of Activating FcγRs in Protection against Influenza Disease by M2e-Specific IgG1 and IgG2a Antibodies.
Van den Hoecke S; Ehrhardt K; Kolpe A; El Bakkouri K; Deng L; Grootaert H; Schoonooghe S; Smet A; Bentahir M; Roose K; Schotsaert M; Schepens B; Callewaert N; Nimmerjahn F; Staeheli P; Hengel H; Saelens X
J Virol; 2017 Apr; 91(7):. PubMed ID: 28077656
[TBL] [Abstract][Full Text] [Related]
22. M2e-tetramer-specific memory CD4 T cells are broadly protective against influenza infection.
Eliasson DG; Omokanye A; Schön K; Wenzel UA; Bernasconi V; Bemark M; Kolpe A; El Bakkouri K; Ysenbaert T; Deng L; Fiers W; Saelens X; Lycke N
Mucosal Immunol; 2018 Jan; 11(1):273-289. PubMed ID: 28295019
[TBL] [Abstract][Full Text] [Related]
23. Increased immunogenicity and protective efficacy of influenza M2e fused to a tetramerizing protein.
Andersson AM; Håkansson KO; Jensen BA; Christensen D; Andersen P; Thomsen AR; Christensen JP
PLoS One; 2012; 7(10):e46395. PubMed ID: 23049700
[TBL] [Abstract][Full Text] [Related]
24. M2e-immobilized gold nanoparticles as influenza A vaccine: Role of soluble M2e and longevity of protection.
Tao W; Gill HS
Vaccine; 2015 May; 33(20):2307-15. PubMed ID: 25842219
[TBL] [Abstract][Full Text] [Related]
25. Influenza A virus infection engenders a poor antibody response against the ectodomain of matrix protein 2.
Feng J; Zhang M; Mozdzanowska K; Zharikova D; Hoff H; Wunner W; Couch RB; Gerhard W
Virol J; 2006 Dec; 3():102. PubMed ID: 17150104
[TBL] [Abstract][Full Text] [Related]
26. Recombinant baculovirus vaccine containing multiple M2e and adjuvant LTB induces T cell dependent, cross-clade protection against H5N1 influenza virus in mice.
Zhang J; Fan HY; Zhang Z; Zhang J; Zhang J; Huang JN; Ye Y; Liao M
Vaccine; 2016 Jan; 34(5):622-629. PubMed ID: 26724200
[TBL] [Abstract][Full Text] [Related]
27. Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies.
De Filette M; Martens W; Smet A; Schotsaert M; Birkett A; Londoño-Arcila P; Fiers W; Saelens X
Vaccine; 2008 Dec; 26(51):6503-7. PubMed ID: 18835315
[TBL] [Abstract][Full Text] [Related]
28. Heterosubtypic protection conferred by combined vaccination with M2e peptide and split influenza vaccine.
Wu F; Yuan XY; Huang WS; Chen YH
Vaccine; 2009 Oct; 27(43):6095-101. PubMed ID: 19056447
[TBL] [Abstract][Full Text] [Related]
29. Complete protection against a H5N2 avian influenza virus by a DNA vaccine expressing a fusion protein of H1N1 HA and M2e.
Park KS; Seo YB; Lee JY; Im SJ; Seo SH; Song MS; Choi YK; Sung YC
Vaccine; 2011 Jul; 29(33):5481-7. PubMed ID: 21664216
[TBL] [Abstract][Full Text] [Related]
30. In contrast to conventional inactivated influenza vaccines, 4xM2e.HSP70c fusion protein fully protected mice against lethal dose of H1, H3 and H9 influenza A isolates circulating in Iran.
Ebrahimi SM; Dabaghian M; Tebianian M; Jazi MH
Virology; 2012 Aug; 430(1):63-72. PubMed ID: 22595444
[TBL] [Abstract][Full Text] [Related]
31. [Immunogenicity of recombinant proteins including ectodomain of M2 influenza virus A].
Stepanova LA; Kovaleva AA; Potapchuk MV; Korotkov AV; Kupriianov VV; Blokhina EA; Kotliarov RIu; Tsybalova LM
Vopr Virusol; 2013; 58(3):21-5. PubMed ID: 24006628
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the murine Th2 response to immunization with liposomal M2e influenza vaccine.
Adler-Moore J; Munoz M; Kim H; Romero J; Tumpey T; Zeng H; Petro C; Ernst W; Kosina S; Jimenez G; Fujii G
Vaccine; 2011 Jun; 29(27):4460-8. PubMed ID: 21545821
[TBL] [Abstract][Full Text] [Related]
33. Vaccine options for influenza: thinking small.
Schepens B; De Vlieger D; Saelens X
Curr Opin Immunol; 2018 Aug; 53():22-29. PubMed ID: 29631195
[TBL] [Abstract][Full Text] [Related]
34. Protective efficacy of a bacterially produced modular capsomere presenting M2e from influenza: extending the potential of broadly cross-protecting epitopes.
Wibowo N; Hughes FK; Fairmaid EJ; Lua LH; Brown LE; Middelberg AP
Vaccine; 2014 Jun; 32(29):3651-5. PubMed ID: 24795225
[TBL] [Abstract][Full Text] [Related]
35. The epitope recognized by a monoclonal antibody in influenza A virus M2 protein is immunogenic and confers immune protection.
Zou P; Liu W; Chen YH
Int Immunopharmacol; 2005 Apr; 5(4):631-5. PubMed ID: 15710332
[TBL] [Abstract][Full Text] [Related]
36. Characterizations of four monoclonal antibodies against M2 protein ectodomain of influenza A virus.
Fu TM; Freed DC; Horton MS; Fan J; Citron MP; Joyce JG; Garsky VM; Casimiro DR; Zhao Q; Shiver JW; Liang X
Virology; 2009 Mar; 385(1):218-26. PubMed ID: 19070878
[TBL] [Abstract][Full Text] [Related]
37. Protection against influenza A virus by vaccination with a recombinant fusion protein linking influenza M2e to human serum albumin (HSA).
Mu X; Hu K; Shen M; Kong N; Fu C; Yan W; Wei A
J Virol Methods; 2016 Feb; 228():84-90. PubMed ID: 26615805
[TBL] [Abstract][Full Text] [Related]
38. [Construction and immunogenicity of recombinant bacteriophage T7 vaccine expressing M2e peptides of avian influenza virus].
Xu H; Wang YW; Tang YH; Zheng QS; Hou JB
Bing Du Xue Bao; 2013 Jun; 29(4):376-81. PubMed ID: 23895000
[TBL] [Abstract][Full Text] [Related]
39. A bispecific antibody recognizing influenza A virus M2 protein redirects effector cells to inhibit virus replication in vitro.
Fernandez-Sesma A; Schulman JL; Moran TM
J Virol; 1996 Jul; 70(7):4800-4. PubMed ID: 8676511
[TBL] [Abstract][Full Text] [Related]
40. Protective efficacy of Fc targeting conserved influenza virus M2e antigen expressed by Lactobacillus plantarum.
Yang WT; Yang GL; Wang Q; Huang HB; Jiang YL; Shi CW; Wang JZ; Huang KY; Jin YB; Wang CF
Antiviral Res; 2017 Feb; 138():9-21. PubMed ID: 27908830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
